Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 647

1.

Osteogenesis of Multipotent Progenitor Cells using the Epigallocatechin Gallate-Modified Gelatin Sponge Scaffold in the Rat Congenital Cleft-Jaw Model.

Sasayama S, Hara T, Tanaka T, Honda Y, Baba S.

Int J Mol Sci. 2018 Nov 29;19(12). pii: E3803. doi: 10.3390/ijms19123803.

2.

Epigallocatechin Gallate-Modified Gelatin Sponges Treated by Vacuum Heating as a Novel Scaffold for Bone Tissue Engineering.

Honda Y, Takeda Y, Li P, Huang A, Sasayama S, Hara E, Uemura N, Ueda M, Hashimoto M, Arita K, Matsumoto N, Hashimoto Y, Baba S, Tanaka T.

Molecules. 2018 Apr 11;23(4). pii: E876. doi: 10.3390/molecules23040876.

3.

A cloud-based home health care information sharing system to connect patients with home healthcare staff -A case report of a study in a mountainous region.

Nomoto S, Utsumi M, Sasayama S, Dekigai H.

Nihon Ronen Igakkai Zasshi. 2017;54(2):165-171. doi: 10.3143/geriatrics.54.165. Japanese.

4.

Efficacy and Safety of an Orally Administered Selective Prostacyclin Receptor Agonist, Selexipag, in Japanese Patients With Pulmonary Arterial Hypertension.

Tanabe N, Ikeda S, Tahara N, Fukuda K, Hatano M, Ito H, Nakayama T, Anzai T, Hashimoto A, Inoue T, Kajinami K, Kihara Y, Kinoshita H, Kuwahara K, Murohara T, Okazaki O, Sakai S, Satoh T, Takeda Y, Takeishi Y, Taniguchi M, Watanabe H, Yamamoto T, Yamauchi-Takihara K, Yoshioka K, Sasayama S.

Circ J. 2017 Aug 25;81(9):1360-1367. doi: 10.1253/circj.CJ-16-1348. Epub 2017 Apr 18.

5.

Efficacy and Safety of a Novel Endothelin Receptor Antagonist, Macitentan, in Japanese Patients With Pulmonary Arterial Hypertension.

Tahara N, Dobashi H, Fukuda K, Funauchi M, Hatano M, Ikeda S, Joho S, Kihara Y, Kimura T, Kondo T, Matsushita M, Minamino T, Nakanishi N, Ozaki Y, Saji T, Sakai S, Tanabe N, Watanabe H, Yamada H, Yoshioka K, Sasayama S.

Circ J. 2016 May 25;80(6):1478-83. doi: 10.1253/circj.CJ-15-1305. Epub 2016 May 13.

6.

Effects of nocturnal oxygen therapy in patients with chronic heart failure and central sleep apnea: CHF-HOT study.

Nakao YM, Ueshima K, Yasuno S, Sasayama S.

Heart Vessels. 2016 Feb;31(2):165-72. doi: 10.1007/s00380-014-0592-6. Epub 2014 Oct 28.

PMID:
25348726
7.

Effects of the endothelin receptor antagonist bosentan on hemodynamics and exercise capacity in Japanese patients with mildly symptomatic pulmonary arterial hypertension.

Hatano M, Yamada H, Fukuda K, Yoshioka K, Funauchi M, Kuwana M, Sata M, Taniguchi M, Nakanishi N, Saito T, Saji T, Sasayama S.

Heart Vessels. 2015 Nov;30(6):798-804. doi: 10.1007/s00380-014-0544-1. Epub 2014 Jul 16.

PMID:
25028167
8.

Evaluation of a new formulation of epoprostenol sodium in Japanese patients with pulmonary arterial hypertension (EPITOME4).

Tamura Y, Ono T, Fukuda K, Satoh T, Sasayama S.

Adv Ther. 2013 May;30(5):459-71. doi: 10.1007/s12325-013-0029-0. Epub 2013 May 8. Erratum in: Adv Ther. 2013 May;30(5):554-5.

9.

Treatment options for Cheyne-Stokes respiration and heart failure.

Sasayama S.

Curr Heart Fail Rep. 2011 Sep;8(3):155-8. doi: 10.1007/s11897-011-0058-4. Review. No abstract available.

PMID:
21491193
10.

Reappraisal of functional importance of coronary collateral circulation.

Fujita M, Sasayama S.

Cardiology. 2010;117(4):246-52. doi: 10.1159/000323499. Epub 2011 Jan 18.

11.

Prognostic effects of combined treatment with calcium channel blockers and statins in patients with coronary narrowing: from the Japanese Coronary Artery Disease study.

Kohro T, Fujita M, Sasayama S, Mitani S, Yamazaki T, Hayashi D, Okada Y, Nagai R; Japanese Coronary Artery Disease Investigators.

Int Heart J. 2010;51(5):299-302.

12.

Treatment effects of renin-angiotensin system inhibitor and calcium channel blocker in patients with coronary artery narrowing (from the Japanese Coronary Artery Disease Study).

Fujita M, Sasayama S, Terasaki F, Mitani S, Morimoto T, Yamazaki T, Hayashi D, Kohro T, Okada Y, Nagai R; JCAD Study Investigators.

Heart Vessels. 2010 Nov;25(6):453-9. doi: 10.1007/s00380-010-0012-5. Epub 2010 Oct 5.

13.

Coronary collateral growth and its therapeutic application to coronary artery disease.

Fujita M, Sasayama S.

Circ J. 2010 Jul;74(7):1283-9. Epub 2010 Jun 15.

14.

Improvement of quality of life with nocturnal oxygen therapy in heart failure patients with central sleep apnea.

Sasayama S, Izumi T, Matsuzaki M, Matsumori A, Asanoi H, Momomura S, Seino Y, Ueshima K; CHF-HOT Study Group.

Circ J. 2009 Jul;73(7):1255-62. Epub 2009 May 18.

15.

Heart disease in Asia.

Sasayama S.

Circulation. 2008 Dec 16;118(25):2669-71. doi: 10.1161/CIRCULATIONAHA.108.837054. No abstract available.

PMID:
19106388
16.

Efficacy of abciximab for patients undergoing balloon angioplasty: data from Japanese evaluation of c7E3 Fab for elective and primary PCI organization in randomized trial (JEPPORT).

Nakagawa Y, Nobuyoshi M, Yamaguchi T, Meguro T, Yokoi H, Kimura T, Hosoda S, Kanmatsuse K, Matsumori A, Sasayama S.

Circ J. 2009 Jan;73(1):145-51. Epub 2008 Nov 21.

17.

Increased serum levels and expression of S100A8/A9 complex in infiltrated neutrophils in atherosclerotic plaque of unstable angina.

Miyamoto S, Ueda M, Ikemoto M, Naruko T, Itoh A, Tamaki S, Nohara R, Terasaki F, Sasayama S, Fujita M.

Heart. 2008 Aug;94(8):1002-7. doi: 10.1136/hrt.2007.121640. Epub 2008 Feb 28.

PMID:
18308864
18.
19.

[Pharmacologic treatment of heart failure: general principle].

Sasayama S.

Nihon Rinsho. 2007 May 28;65 Suppl 5:7-13. Review. Japanese. No abstract available.

PMID:
17571359
20.

Long-term trial of bosentan monotherapy for pulmonary arterial hypertension in Japanese patients.

Sasayama S, Satoh T, Izumi T, Yoshida S, Kyotani S, Tahara N.

Curr Med Res Opin. 2007 Feb;23(2):395-400.

PMID:
17288693
21.

Synthesis of glycosylated human tumor necrosis factor alpha coupled with N-acetylneuraminic acid.

Hayashi A, Chiba T, Hayashi H, Sasayama S, Ishiguro T, Onozaki K.

Cancer Immunol Immunother. 2007 Apr;56(4):545-53. Epub 2006 Oct 10.

PMID:
17031642
22.

N-acetylneuraminic acid coupled human recombinant TNFalpha exhibits enhanced anti-tumor activity against Meth-A fibrosarcoma and reduced toxicity.

Hayashi A, Hayashi H, Chiba T, Sasayama S, Onozaki K.

Cancer Immunol Immunother. 2007 Apr;56(4):555-62. Epub 2006 Oct 10.

PMID:
17031641
23.

[Home oxygen therapy (HOT) for patients with heart failure associated with sleep disturbed breathing].

Sasayama S.

Nihon Rinsho. 2006 May;64(5):968-73. Review. Japanese.

PMID:
16689382
24.

Effects of nocturnal oxygen therapy on outcome measures in patients with chronic heart failure and cheyne-stokes respiration.

Sasayama S, Izumi T, Seino Y, Ueshima K, Asanoi H; CHF-HOT Study Group.

Circ J. 2006 Jan;70(1):1-7.

25.

Preformed angiotensin II is present in human mast cells.

Hara M, Ono K, Wada H, Sasayama S, Matsumori A.

Cardiovasc Drugs Ther. 2004 Nov;18(6):415-20.

PMID:
15770428
26.

Serum thioredoxin and alpha-tocopherol concentrations in patients with major risk factors.

Miwa K, Kishimoto C, Nakamura H, Makita T, Ishii K, Okuda N, Yodoi J, Sasayama S.

Circ J. 2005 Mar;69(3):291-4.

27.

Recent insights into the mechanisms, predisposing factors, and racial differences of coronary vasospasm.

Miwa K, Fujita M, Sasayama S.

Heart Vessels. 2005 Feb;20(1):1-7. Review.

PMID:
15700195
28.

Effects of the endothelin receptor antagonist bosentan on hemodynamics, symptoms and functional capacity in Japanese patients with severe pulmonary hypertension.

Sasayama S, Kunieda T, Tomoike H, Matsuzaki M, Shirato K, Kuriyama T, Izumi T, Origasa H, Giersbergen PL, Dingemanse J, Tanaka S.

Circ J. 2005 Feb;69(2):131-7. Erratum in: Circ J. 2005 Aug;69(8):1007.

29.

Hydrocortisone reduces restenosis after stenting of small coronary arteries.

Kakio T, Matsumori A, Ohashi N, Yamada T, Saito T, Kawamoto A, Taguchi A, Morita Y, Takahashi M, Sasayama S.

J Interv Cardiol. 2004 Oct;17(5):295-300.

PMID:
15491332
30.
31.
32.

Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.

Hori M, Sasayama S, Kitabatake A, Toyo-oka T, Handa S, Yokoyama M, Matsuzaki M, Takeshita A, Origasa H, Matsui K, Hosoda S; MUCHA Investigators.

Am Heart J. 2004 Feb;147(2):324-30.

PMID:
14760332
33.

The effect of hydrocortisone on reducing rates of restenosis and target lesion revascularization after coronary stenting less than 3 mm in stent diameter.

Kakio T, Matsumori A, Ohashi N, Yamada T, Nobuhara M, Saito T, Kawamoto A, Taguchi A, Morita Y, Takahashi M, Sasayama S.

Intern Med. 2003 Nov;42(11):1084-9.

34.
35.

Gene expression of cardiac mast cell chymase and tryptase in a murine model of heart failure caused by viral myocarditis.

Kitaura-Inenaga K, Hara M, Higuchi K, Yamamoto K, Yamaki A, Ono K, Nakano A, Kinoshita M, Sasayama S, Matsumori A.

Circ J. 2003 Oct;67(10):881-4.

36.

Marked elevation of vascular endothelial growth factor and basic fibroblast growth factor in pericardial fluid of patients with angina pectoris.

Fujita M, Ikemoto M, Tanaka T, Tamaki S, Yamazato A, Sawamura T, Hasegawa K, Kihara Y, Nohara R, Sasayama S.

Angiogenesis. 1998;2(1):105-8.

PMID:
14517380
37.

[Men's health study: current status of erectile dysfunction of 6,112 ambulatory patients at general practitioners offices in Japan].

Sasayama S, Ishii N, Ishikura F, Kamijima G, Ogawa S, Kanmatsuse K, Kimoto Y, Sakuma I, Nonogi H, Matsumori A, Yamamoto Y.

J Cardiol. 2003 Aug;42(2):57-65. Japanese.

PMID:
12964515
38.

Men's Health Study: epidemiology of erectile dysfunction and cardiovascular disease.

Sasayama S, Ishii N, Ishikura F, Kamijima G, Ogawa S, Kanmatsuse K, Kimoto Y, Sakuma I, Nonogi H, Matsumori A, Yamamoto Y.

Circ J. 2003 Aug;67(8):656-9.

39.

Temocapril treatment ameliorates autoimmune myocarditis associated with enhanced cardiomyocyte thioredoxin expression.

Yuan Z, Kishimoto C, Shioji K, Nakamura H, Yodoi J, Sasayama S.

Mol Cell Biochem. 2003 Jun;248(1-2):185-92.

PMID:
12870672
40.

[Inotropic agents].

Sasayama S.

Nihon Rinsho. 2003 May;61(5):807-14. Review. Japanese.

PMID:
12755007
41.

Increased oxidative stress with elevated serum thioredoxin level in patients with coronary spastic angina.

Miwa K, Kishimoto C, Nakamura H, Makita T, Ishii K, Okuda N, Taniguchi A, Shioji K, Yodoi J, Sasayama S.

Clin Cardiol. 2003 Apr;26(4):177-81.

42.
43.

Thrombosis increases circulatory hepatocyte growth factor by degranulation of mast cells.

Kinoshita M, Miyamoto T, Ohashi N, Sasayama S, Matsumori A.

Circulation. 2002 Dec 10;106(24):3133-8.

PMID:
12473563
44.
45.

Broad antiproliferative effects of benidipine on cultured human mesangial cells in cell cycle phases.

Ono T, Liu N, Kusano H, Nogaki F, Makino T, Muso E, Sasayama S.

Am J Nephrol. 2002 Sep-Dec;22(5-6):581-6.

PMID:
12381964
46.

Inotropic agents and immune modulation.

Sasayama S.

Cardiovasc Drugs Ther. 2002 May;16(3):237-43.

PMID:
12374902
47.

Cardiovascular medicine in the region--status report by the Asian-Pacific Society of Cardiology.

Tonkin A, Sloman G, Kumar A, Siddiqui HK, Noohi F, Shimokawa H, Takeshita A, Takekoshi N, Sasayama S, Samad A, Ortiz EE, Ng R, Stephen JS, Kong CW, Chen LC, Chiang CE, Ding PY.

Asian Cardiovasc Thorac Ann. 2002 Sep;10(3):20A-30A. No abstract available.

PMID:
12322692
48.

Heminephrectomy causes the progression of glomerulosclerosis and apoptosis in high IgA strain ddY mice.

Kusano H, Muso E, Ono T, Nogaki F, Nomura K, Takeda T, Miyawaki S, Matsumori A, Yoshida H, Sasayama S.

Nephron. 2002 Oct;92(2):389-98.

PMID:
12218319
49.

[Significance of the antioxidant factor, thioredoxin, in heart failure].

Shioji K, Kishimoto C, Nakamura H, Yodoi J, Sasayama S.

J Cardiol. 2002 Aug;40(2):59-63. Japanese.

PMID:
12194644
50.

Shunt between the ventricular chamber and coronary arteries preserves left ventricular function in acute myocardial infarction.

Miyamoto S, Fujita M, Ueda K, Tamaki S, Hasegawa K, Nagaya N, Sasayama S.

Circ J. 2002 Jul;66(7):633-8.

Supplemental Content

Loading ...
Support Center